Vigil Cardenal Catalina, Mahfooz Kashif, Garcia-Rates Sara, Hasan Sibah, Greenfield Susan. Therapeutic antagonism of a key toxin driving Alzheimer’s disease. Comparison of a peptide variant and small molecule. March 2026. http://View PDF IF 7.5
Georgina Bonny, Kashif Mahfooz, Sara Garcia-Rates, Sibah Hasan and Susan Adele Greenfield.Evaluating the Efficacy of Monoclonal Antibodies Against a Bioactive Peptide Involved in Alzheimer’s Disease: A Methodological Approachhttps://www.mdpi.com/2409-9279/9/3/74
Komorowska, J., Ranglani, S., McCann, H. et al. Increases in a pivotal bioactive peptide in specific brain regions reflect the progression of pathology in Alzheimer’s disease. Alz Res Therapy (2026). https://link.springer.com/article/10.1186/s13195-026-02161-x
Khan, A.M.; García-Ayllón, M.-S.; Hollings, O.; Garcia-Ratés, S.; Greenfield, S. A Novel Regulatory System in Brain Development and Death Driven by a Bioactive Peptide Linked to a Specific Isoform of Acetylcholinesterase. Biomolecules 2026, 16, 1336.
Hasan S, Garcia-Ratés S, Greenfield SA. Site-selective blocking of a bioactive peptide driving neurodegeneration in the rat brain by its cyclised analogue. Mol Neurobiol. 2026 Aug 3;63(1):802. https://pubmed.ncbi.nlm.nih.gov/42545444/